다우존스 지수

실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Akero Therapeutics Inc (AKRO)
Akero Therapeutics Inc (AKRO) 뉴스

AKRO

Akero Therapeutics (AKRO)

Akero Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:AKRO

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/11	05:57	Edgar (US Regulatory)	Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers	NASDAQ:AKRO	Akero Therapeutics Inc
2024/05/10	20:30	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:AKRO	Akero Therapeutics Inc
2024/05/10	20:17	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AKRO	Akero Therapeutics Inc
2024/05/10	20:00	GlobeNewswire Inc.	Akero Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update	NASDAQ:AKRO	Akero Therapeutics Inc
2024/05/08	20:00	GlobeNewswire Inc.	Akero Therapeutics to Present at the BofA Securities 2024 Health Care Conference	NASDAQ:AKRO	Akero Therapeutics Inc
2024/04/30	21:00	GlobeNewswire Inc.	Akero Therapeutics Appoints Scott Gangloff as Chief Technology Officer	NASDAQ:AKRO	Akero Therapeutics Inc
2024/03/09	06:02	GlobeNewswire Inc.	Akero Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares	NASDAQ:AKRO	Akero Therapeutics Inc
2024/03/08	06:01	GlobeNewswire Inc.	Akero Therapeutics Announces Publication of Phase 2b SYMMETRY Cohort D Study in Clinical Gastroenterology and Hepatology	NASDAQ:AKRO	Akero Therapeutics Inc
2024/03/07	10:14	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AKRO	Akero Therapeutics Inc
2024/03/07	10:13	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AKRO	Akero Therapeutics Inc
2024/03/07	07:25	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AKRO	Akero Therapeutics Inc
2024/03/07	07:16	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:AKRO	Akero Therapeutics Inc
2024/03/06	11:13	GlobeNewswire Inc.	Akero Therapeutics Announces Pricing of Public Offering of Common Stock	NASDAQ:AKRO	Akero Therapeutics Inc
2024/03/06	07:16	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AKRO	Akero Therapeutics Inc
2024/03/05	20:05	IH Market News	AMD Hits Regulatory Roadblock, GitLab’s Stock Tumbles on Disappointing Earnings, and Latest News	NASDAQ:AKRO	Akero Therapeutics Inc
2024/03/05	07:34	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:AKRO	Akero Therapeutics Inc
2024/03/05	07:30	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:AKRO	Akero Therapeutics Inc
2024/03/05	07:21	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:AKRO	Akero Therapeutics Inc
2024/03/05	06:21	GlobeNewswire Inc.	Akero Therapeutics Announces Proposed Public Offering of Common Stock	NASDAQ:AKRO	Akero Therapeutics Inc
2024/03/04	21:55	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AKRO	Akero Therapeutics Inc
2024/03/04	20:00	GlobeNewswire Inc.	Akero Therapeutics Reports Statistically Significant Histological Improvements at Week 96 in Phase 2b HARMONY Study	NASDAQ:AKRO	Akero Therapeutics Inc
2024/03/01	06:42	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:AKRO	Akero Therapeutics Inc
2024/02/29	22:00	GlobeNewswire Inc.	Akero Therapeutics to Present Topline Week 96 Results from Phase 2b HARMONY Study Investigating Efruxifermin in Patients with Pre-Cirrhotic MASH	NASDAQ:AKRO	Akero Therapeutics Inc
2024/02/29	21:30	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:AKRO	Akero Therapeutics Inc
2024/02/29	21:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AKRO	Akero Therapeutics Inc
2024/02/29	21:00	GlobeNewswire Inc.	Akero Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update	NASDAQ:AKRO	Akero Therapeutics Inc
2024/02/14	11:40	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:AKRO	Akero Therapeutics Inc
2024/01/04	07:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AKRO	Akero Therapeutics Inc
2024/01/03	22:15	GlobeNewswire Inc.	Akero Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference	NASDAQ:AKRO	Akero Therapeutics Inc
2023/12/30	10:30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AKRO	Akero Therapeutics Inc

검색 관련기사 보기:NASDAQ:AKRO

1 2 3 4 5 6 7 8 9 10 다음 >>

Murray Cod Australia

영원무역홀딩스

Global X Autonomous & El...

Totalenergies Internatio...

Vontobel Financial Produ...

Sweden Tf 2,5% Mg25 Sek

Chroma (Chromia)

Vontobel Financial Produ...

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관